The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1
T.C. Booth(National Hospital for Neurology and Neurosurgery), John Buscombe(University of Cambridge), Adam Waldman(Royal Society of Edinburgh), Anthony H.V. Schapira(National Hospital for Neurology and Neurosurgery), Malavika Nathan(National Health Service), Ann‐Marie Quigley(National Health Service)
Cited by 83
Related Papers
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
|Movement Disorders|2006|1.1k
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
|Human Molecular Genetics|2010|896
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Mitochondrial defect in Huntington's disease caudate nucleus
|Annals of Neurology|1996|738